Multiplex Assays Market to be Worth $6.24 Billion by 2030
Meticulous Research®—a leading global market research company, published a research report titled, ‘Multiplex Assays Market by Type (Protein [Bead, Planar], Nucleic Acid, Cell) Technology (Flow Cytometry, PCR, Immunoassay) Application (R&D, Diagnosis (Oncology, Cardiovascular, Infectious, Autoimmune Diseases) Product, End User - Global Forecast to 2030.’
According to this latest publication from Meticulous Research®, the global multiplex assays market is projected to reach $6.24 billion by 2030 at a CAGR of 9%. The growth of this market is attributed to several factors, including growing awareness about early disease diagnosis, significant advantages of multiplex assays over traditional methods, increasing use of multiplex assays in drug discovery & development, and rising prevalence of chronic and infectious diseases. However, the high costs of multiplex assay equipment restrain the growth of this market. The growing need for high-throughput and automated laboratory systems and the increasing focus on personalized medicine are expected to generate growth opportunities for the players operating in this market. However, the shortage of skilled professionals and the risk of cross-reactivity are major challenges to market growth.
Key Players
The key players operating in the global multiplex assays market are Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Seegene, Inc. (South Korea), QIAGEN N.V. (Netherlands), PerkinElmer, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Agilent Technologies, Inc. (U.S.), Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), Illumina, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Quanterix Corporation (U.S.), DiaSorin S.p.A. (Italy), and Merck KGaA (Germany).
Multiplex Assays Market: Future Outlook
The global multiplex assays market is segmented by Type (Protein Multiplex Assays [Bead-based Assays, Planar Assays], Nucleic Acid Multiplex Assays, Cell-based Multiplex Assays), Product (Consumables, Instruments, Software), Technology (Flow Cytometry, Multiplex Immunoassay, Multiplex Real-time PCR, Sequencing, Other Technologies), Application (Research & Development, Clinical Diagnosis [Infectious Diseases, Oncology, Cardiovascular Diseases, Autoimmune Diseases, Other Diseases]) and Geography. The study also evaluates industry competitors and analyzes their market share at global and regional levels.
Among all types studied in this report, in 2023, the protein multiplex assays segment is expected to account for the largest share of the multiplex assays market. Protein multiplex assays are increasingly used to study protein pathways and biomarker development. Some application areas of protein multiplex assays are clinical biomarker development, comprehensive proteomic surveys, validation of genomic discoveries, and studies of protein networks and pathways. Protein assays are also used in clinical trials as they offer quick analysis, reduce labor costs, and decrease the chances of manual error, which increases research efficiency.
Among all products studied in this report, the consumables segment is expected to grow at the highest CAGR during the forecast period. The continuous advancements in the development of reagents and kits, the adoption of multiplex assays diagnostic kits for disease diagnosis, and ease of use are increasing the demand for consumables used in multiplex assays.
Download Sample Report Here @
https://www.meticulousresearch.com/download-sample-report/cp_id=5598 Multiplex Assays Market to be Worth $6.24 Billion by 2030
Meticulous Research®—a leading global market research company, published a research report titled, ‘Multiplex Assays Market by Type (Protein [Bead, Planar], Nucleic Acid, Cell) Technology (Flow Cytometry, PCR, Immunoassay) Application (R&D, Diagnosis (Oncology, Cardiovascular, Infectious, Autoimmune Diseases) Product, End User - Global Forecast to 2030.’
According to this latest publication from Meticulous Research®, the global multiplex assays market is projected to reach $6.24 billion by 2030 at a CAGR of 9%. The growth of this market is attributed to several factors, including growing awareness about early disease diagnosis, significant advantages of multiplex assays over traditional methods, increasing use of multiplex assays in drug discovery & development, and rising prevalence of chronic and infectious diseases. However, the high costs of multiplex assay equipment restrain the growth of this market. The growing need for high-throughput and automated laboratory systems and the increasing focus on personalized medicine are expected to generate growth opportunities for the players operating in this market. However, the shortage of skilled professionals and the risk of cross-reactivity are major challenges to market growth.
Key Players
The key players operating in the global multiplex assays market are Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Seegene, Inc. (South Korea), QIAGEN N.V. (Netherlands), PerkinElmer, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Agilent Technologies, Inc. (U.S.), Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), Illumina, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Quanterix Corporation (U.S.), DiaSorin S.p.A. (Italy), and Merck KGaA (Germany).
Multiplex Assays Market: Future Outlook
The global multiplex assays market is segmented by Type (Protein Multiplex Assays [Bead-based Assays, Planar Assays], Nucleic Acid Multiplex Assays, Cell-based Multiplex Assays), Product (Consumables, Instruments, Software), Technology (Flow Cytometry, Multiplex Immunoassay, Multiplex Real-time PCR, Sequencing, Other Technologies), Application (Research & Development, Clinical Diagnosis [Infectious Diseases, Oncology, Cardiovascular Diseases, Autoimmune Diseases, Other Diseases]) and Geography. The study also evaluates industry competitors and analyzes their market share at global and regional levels.
Among all types studied in this report, in 2023, the protein multiplex assays segment is expected to account for the largest share of the multiplex assays market. Protein multiplex assays are increasingly used to study protein pathways and biomarker development. Some application areas of protein multiplex assays are clinical biomarker development, comprehensive proteomic surveys, validation of genomic discoveries, and studies of protein networks and pathways. Protein assays are also used in clinical trials as they offer quick analysis, reduce labor costs, and decrease the chances of manual error, which increases research efficiency.
Among all products studied in this report, the consumables segment is expected to grow at the highest CAGR during the forecast period. The continuous advancements in the development of reagents and kits, the adoption of multiplex assays diagnostic kits for disease diagnosis, and ease of use are increasing the demand for consumables used in multiplex assays.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5598